Similar articles

• [Conjugated vaccines].

  Swennen B, Sternon J. Swennen B, et al. Rev Med Brux. 2002 Jun;23(3):165-74. Rev Med Brux. 2002. PMID: 12143156 Review. French.
• Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.

  Trotter CL, McVernon J, Ramsay ME, Whitney CG, Mulholland EK, Goldblatt D, Hombach J, Kieny MP; SAGE subgroup. Trotter CL, et al. Vaccine. 2008 Aug 18;26(35):4434-45. doi: 10.1016/j.vaccine.2008.05.073. Epub 2008 Jun 17. Vaccine. 2008. PMID: 18617296 Review.
• A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.

  Pace D, Snape M, Westcar S, Hamaluba M, Yu LM, Begg N, Wysocki J, Czajka H, Maechler G, Boutriau D, Pollard AJ. Pace D, et al. Pediatr Infect Dis J. 2007 Nov;26(11):1057-9. doi: 10.1097/INF.0b013e31813429fa. Pediatr Infect Dis J. 2007. PMID: 17984816 Clinical Trial.
• Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines.

  Ciruela P, Martínez A, Izquierdo C, Hernández S, Broner S, Muñoz-Almagro C, Domínguez À; Microbiological Reporting System of Catalonia Study Group. Ciruela P, et al. Hum Vaccin Immunother. 2013 Mar;9(3):681-91. doi: 10.4161/hv.23266. Epub 2013 Jan 9. Hum Vaccin Immunother. 2013. PMID: 23303166 Free PMC article.
• Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.

  Wysocki J, Tejedor JC, Grunert D, Konior R, Garcia-Sicilia J, Knuf M, Bernard L, Dieussaert I, Schuerman L. Wysocki J, et al. Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S77-88. doi: 10.1097/INF.0b013e318199f609. Pediatr Infect Dis J. 2009. PMID: 19325450 Clinical Trial.